The rising threat of Mpox in Japan despite global decrease

Springer Science and Business Media LLC - Tập 44 - Trang 499-502 - 2023
Yudai Kaneda1, Rajeev Shrestha2, Kota Iwahashi3, Kenzo Takahashi4
1School of Medicine, Hokkaido University, Sapporo, Japan
2Palliative Care and Chronic Disease, Green Pasture Hospital, Pokhara, Nepal
3Community Center Akta, Tokyo, Japan
4Teikyo University Graduate School of Public Health, Tokyo, Japan

Tài liệu tham khảo

Ministry of Health, Labor and Welfare. About Monkeypox [in Japanese]. 2023 Available from: https://www.mhlw.go.jp/stf/seisakunitsuite/bunya/kenkou/kekkaku-kansenshou19/monkeypox_00001.html. Accessed 18 April 2023. O’Laughlin K, et al. Clinical use of tecovirimat (Tpoxx) for treatment of monkeypox under an investigational new drug protocol—United States, May-August 2022. MMWR Morb Mortal Wkly Rep. 2022;71(37):1190–5. McQuiston, J.H., The CDC domestic Mpox response—United States, 2022–2023. MMWR. Morbidity and Mortality Weekly Report, 2023;72:80. Thornhill JP, et al. Monkeypox virus infection in humans across 16 countries—April-June 2022. N Engl J Med. 2022;387(8):679–91. Wang Y, et al. Elimination of HIV transmission in Japanese MSM with combination interventions. Lancet Reg Health West Pac. 2022;23: 100467. Yu F, et al. The influence of anticipated HIV stigma on health-related behaviors, self-rated health, and treatment preferences among people living with HIV in East Asia. AIDS Behav. 2023;27(4):1287–303. Traore T, et al. How prepared is the world? Identifying weaknesses in existing assessment frameworks for global health security through a One Health approach. The Lancet. 2023;401(10377):673–87. Brown HL, et al. The One Health European Joint Programme (OHEJP), 2018–2022: an exemplary One Health initiative. J Med Microbiol. 2020;69(8):1037–9.